# A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)

> **NCT00067743** · PHASE2 · COMPLETED · sponsor: **Celgene Corporation** · enrollment: 40 (actual)

## Conditions studied

- Complex Regional Pain Syndrome (RSD)

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT00067743
- **Lead sponsor:** Celgene Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2004-10
- **Final completion:** 2007-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067743, "A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00067743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*